Navigation Links
ConforMIS Completes Executive Team With Addition of CFO
Date:5/5/2008

BURLINGTON, Mass., May 5 /PRNewswire/ -- ConforMIS, Inc., a privately held company that develops and commercializes minimally invasive medical devices for the treatment of osteoarthritis and joint damage, today announced the appointment of Ms. Judith Huber to Chief Financial Officer. The addition fully rounds out the executive team, which includes recently named Chairman Philipp Lang, MD, as Chief Executive Officer and Phil Licari as Chief Operating Officer.

Ms. Huber brings more than 20 years of financial experience, predominately in the medical device industry, to ConforMIS. Most recently, Ms. Huber served as Vice President and Controller at NxStage Medical where she was instrumental in building the financial and administrative infrastructure that led to the company's initial public offering, secondary financing and acquisition of Medisystems Corporation.

"We are extremely pleased to welcome Judy as the final member of the ConforMIS executive team," said Chairman and CEO Philipp Lang, MD. "Judy joins ConforMIS at an exciting time in our company's history as we've seen demand across the globe for our line of patient-specific implants increase substantially. Her experience in building financial infrastructure to support growth on both the operations and commercialization fronts will play a key role as we head into the second half of 2008 and beyond."

Prior to joining NxStage Medical, Ms. Huber spent more than nine years in various financial positions with C. R. Bard and AVE/Medtronic. She supported multiple divisions focused on improving the economic efficiencies of their manufacturing operations.

"I'm looking forward to working with an accomplished team of executives at such an important and exciting time in ConforMIS' growth," said Ms. Huber. "Delivering on the opportunity to build a robust financial capability for ConforMIS will enable the company to continue on the path to becoming a major player in the orthopedic market."

Ms. Huber earned a B.S. in Accounting from the State University of New York at Geneseo and an M.B.A. from the Babson College. She is also a Certified Management Accountant.

About ConforMIS, Inc.

ConforMIS, Inc. is a privately held company incorporated in 2004 that develops and commercializes medical devices for the treatment of osteoarthritis and joint damages. The Company's novel and scaleable 'image-to-implant' process is comprised of two related technology platforms. iFit(TM) Technology enables the creation of conforming, patient-specific implants that are precisely sized and shaped to match the 3D topography of the patient's bone surfaces. The iJig(TM) Instrumentation enables the creation of novel, disposable cutting and placement guides that simplify and improve the surgical process.

Both platforms are supported by proprietary, intellectual property consisting of more than 120 issued patents or pending patent applications that span imaging software, image processing, implant design, surgical techniques and instrumentation.

To date, ConforMIS has developed a comprehensive line of minimally traumatic, bone and cartilage-preserving knee implants and instrumentation designed to address all stages of osteoarthritis, the most common reason for knee replacement surgery. Each device has been cleared by the U.S. Food and Drug Administration for marketing in the U.S.

ConforMIS, Inc. Contact:

Jong Lee

Senior Vice President, Marketing

781-345-9107

Media Contact:

Sally Bain

Racepoint Group

781-487-4647

sbain@racepointgroup.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ConforMIS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving the ... has teamed up with Citizens Opposed to Domestic Abuse in support of its efforts ... all those victimized by the fear of violence in their own homes, donations may ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted February 8, ... West Awards. , Awards include the Information Security Executive® of the ...
(Date:2/8/2016)... ... , ... Discover the Rocky Mountain region’s longest running and impressive garden and ... also get to see the most incredible gardens and home improvement experts that attend ... Colorado Convention Center - 700 14th St. Denver CO, is an exciting event that ...
(Date:2/8/2016)... Las Vegas, Nevada (PRWEB) , ... February 08, ... ... Co-Founder at RowdMap, Inc., will be speaking on how healthcare companies can use ... project costs, manage the health of a population and intervene and capture the ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... with the latest techniques and the most minimally invasive approaches. , Women who ... particularly after menopause. Other risk factors include surgery to the pelvic floor, connective ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... SAN DIEGO , Feb. 8, 2016 /PRNewswire/--  ... have announced that advanced tissue-engineering services are now ... using a groundbreaking new three-dimensional (3D) bioprinting approach ... Regenova® 3D Bio Printer , a state-of-the-art robotic ... Applications has created a powerful pay-for-service bio-printing model ...
(Date:2/8/2016)... Feb. 8, 2016  Avista Pharma Solutions ("Avista Pharma") ... as Chief Financial Officer (CFO). Mr. Setzer is a ... experience in various roles within growing technology and life ... as the Executive Director of Finance at INC Research, ... Raleigh, NC . Previously, Mr. Setzer served as ...
(Date:2/8/2016)... 8, 2016 Velano Vascular, a medical technology ... patients and their practitioners, announced today that the company ... will use the proceeds from this financing, an extension ... January 2015, to support the development and commercialization of ... populations. Philadelphia , and ...
Breaking Medicine Technology: